The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort

Clinical Rheumatology

Volumn 33, Issue 4, 2014, Pages 549-553

  Duskin Bitan, Hadar ^a,b   Cohen, Eytan ^a,b   Goldberg, Elad ^a,b   Shochat, Tzippy ^a   Levi, Amos ^a,b   Garty, Moshe ^a,b   Krause, Ilan ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alcohol; Arthritis; Gender; Renal function; Thiazide; Uric acid

Indexed keywords

ALCOHOL; THIAZIDE DIURETIC AGENT; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASYMPTOMATIC HYPERURICEMIA; DRUG USE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GOUT; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; URIC ACID BLOOD LEVEL; AGED; ASYMPTOMATIC DISEASE; BLOOD; COHORT ANALYSIS; DRINKING BEHAVIOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ASYMPTOMATIC DISEASES; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; GOUT; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS; URIC ACID; YOUNG ADULT;

EID: 84898927001     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2520-7     Document Type: Article

References (25)

1. Neogi T (2011) Gout. N Engl J Med 364:443-452
2. Campion EW, Glynn RJ, DeLabry LO (1987) Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 82:421-426
3. Hall AP, Barry PE, Dawber TR, McNamara PM (1967) Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med 42:27-37
4. Roubenoff R (1990) Gout and hyperuricemia. Rheum Dis Clin North Am 6:539-550
5. Trifirò G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M et al (2013) Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis 72:694-700
6. Zhu Y, Pandya BJ, Choi HK (2012) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med 125:679-687
7. Arromdee E (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403-2406
8. Roddy E (2007) The changing epidemiology of gout. Nat Clin Pract Rheumatol 3:443-449
9. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 67:960-966
10. Klemp P, Stansfield SA, Castle B, Robertson MC (1997) Gout is on the increase in New Zealand. Ann Rheum Dis 56:22-26
11. Mikuls T, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 64:267-272
12. Gutiérrez-Macías A, Lizarralde-Palacios E, Martínez-Odriozola P, Miguel-De la Villa F (2005) Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. BMJ 331:623-624
13. Hammer B, Link A, Wagner A, Böhm M (2001) Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome. Dtsch Med Wochenschr 126:1331-1334
14. Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 64:1447-1461
15. Kratz A, Pesce MA, Fink DJ (2012) Laboratory values of clinical importance. In: Fauci AS, Braunwald E, Kasper D et al (eds) Harrison principles of internal medicine, 18th edn. McGraw Hill, New York, USA, p 3596
16. Min SI, Yun IJ, Kang JM, Park YJ, Min SK, Ahn C et al (2009) Moderate to severe early onset hyperuricemia: a prognostic marker of long term kidney transplant outcome. Nephrol Dial Transplant 24:2584-2590
17. Schumacher HR, Chen LX (2012) Gout and other crystal-associated arthropathies. In: Fauci AS, Braunwald E, Kasper D et al (eds) Harrison principles of internal medicine, 18th edn. McGraw Hill, New York, USA, pp 2012-2837
18. Lally E, Ho G Jr, Kaplan SR (1986) The clinical spectrum of gouty arthritis in women. Arch Intern Med 146:2221-2225
19. Puig J, Michán AD, Jiménez ML, Pérez de Ayala C, Mateos FA, Capitán CF et al (1991) Female gout. Clinical spectrum and uric acid metabolism. Arch Intern Med 151:726-732
20. Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35:1859-1864
21. Langford HG, Blaufox MD, Borhani NO, Curb JD, Molteni A, Schneider KA et al (1987) Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 47:645-649
22. Choi HK, Soriano LC, Zhang Y, Rodríguez LA (2012) Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 344:d8190:1-9
23. Lin KC, Chou P (2000) The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 27:1501-1505
24. Cohen E, Krause I, Fraser A, Goldberg E, Garty M (2012) Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel. IMAJ 14:676-680
25. Bilenko N, Fraser D, Vardi H, Shai I, Shahar DR (2005) Mediterranean diet and cardiovascular diseases in an Israeli population. Prev Med 40:299-305